[Digestive Kaposi's sarcoma in patients with kidney transplantation--report of 2 cases] NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Digestive Kaposi's sarcoma in patients with kidney transplantation--report of 2 cases]

Acta Gastroenterol Latinoam. 1985;15(1):55-62. Unique Identifier : AIDSLINE MED/86125940
Duncan CR; Tani RD; Palmitano JB; Predari S; Aguirre C; Alvarez C


Abstract: Malignant tumors occur with greater frequency in patients with kidney transplants. Kaposi's sarcoma (KS), a rare vascular neoformation, represents approximately 3% of them. Its uncertain etiology appears to respond to: a chronic antigen stimulation by the transplanted tissue, to a depression of immune responsiveness, to the direct oncogenic action of the immunosuppressive agents, to the activation of oncogenic viruses or to a genetic predisposition of other possible factors. The clinical evolution is presented in two immunosuppressed kidney transplant patients with this pathology in the digestive tract. One had remission of the lesion following the suspension of the immunosuppressive agent. The relationship of this tumor with acquired immunodeficiency syndrome which occurred primarily (75%) in homosexuals shows a mortality rate of 30% due to KS. The first case showed signs of digestive hemorrhage and the typical nodule of KS was found in the esophagus on endoscopy. She also suffered a severe mixed infection due to Streptococcus faecalis and Cryptococcus neoformans with neurological complications and a new endoscopy 4 months after suspension of azathioprine showed the disappearance of the esophageal as well as the skin lesions. In the second patient, the suspicion of the digestive tract involvement could only be proved at autopsy. We insist on the importance of immunosuppression as a predisposing factor for the appearance of KS and infections in transplanted patients. It should also be remembered in cases with mucocutaneous lesions, that any digestive hemorrhage must primarily be attributed to KS and that the suspension of the immunosuppressive therapy constitutes the most effective treatment for the tumor.
Keywords: Adult Case Report Digestive System Neoplasms/*ETIOLOGY/PATHOLOGY English Abstract Female Graft Rejection Human Immunosuppressive Agents/*ADVERSE EFFECTS Kidney/*TRANSPLANTATION *Kidney Transplantation Male Sarcoma, Kaposi's/*ETIOLOGY/PATHOLOGY JOURNAL ARTICLE

KWDadultcasereportdigestivesystemneoplasms/KWDetiology/pathologyenglishabstractfemalegraftrejectionhumanimmunosuppressiveagents/KWDadverseeffectskidney/KWDtransplantationKWDkidneytransplantationmalesarcoma,kaposi's/KWDetiology/pathologyjournalarticle
860530
M8650177


Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .